JPWO2023198854A5 - - Google Patents

Info

Publication number
JPWO2023198854A5
JPWO2023198854A5 JP2024559887A JP2024559887A JPWO2023198854A5 JP WO2023198854 A5 JPWO2023198854 A5 JP WO2023198854A5 JP 2024559887 A JP2024559887 A JP 2024559887A JP 2024559887 A JP2024559887 A JP 2024559887A JP WO2023198854 A5 JPWO2023198854 A5 JP WO2023198854A5
Authority
JP
Japan
Prior art keywords
aqueous composition
psicose
weight
amount
hexylglycerin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024559887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513034A (ja
JP2025513034A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/059722 external-priority patent/WO2023198854A1/en
Publication of JP2025513034A publication Critical patent/JP2025513034A/ja
Publication of JPWO2023198854A5 publication Critical patent/JPWO2023198854A5/ja
Publication of JP2025513034A5 publication Critical patent/JP2025513034A5/ja
Pending legal-status Critical Current

Links

JP2024559887A 2022-04-14 2023-04-13 プシコースの新規使用 Pending JP2025513034A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22168287.5 2022-04-14
EP22168287 2022-04-14
PCT/EP2023/059722 WO2023198854A1 (en) 2022-04-14 2023-04-13 Novel use of psicose

Publications (3)

Publication Number Publication Date
JP2025513034A JP2025513034A (ja) 2025-04-22
JPWO2023198854A5 true JPWO2023198854A5 (https=) 2026-03-18
JP2025513034A5 JP2025513034A5 (https=) 2026-03-18

Family

ID=81327995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559887A Pending JP2025513034A (ja) 2022-04-14 2023-04-13 プシコースの新規使用

Country Status (6)

Country Link
US (1) US20250248916A1 (https=)
EP (1) EP4507670A1 (https=)
JP (1) JP2025513034A (https=)
KR (1) KR20250018480A (https=)
CN (1) CN119031898A (https=)
WO (1) WO2023198854A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025145420A1 (en) * 2024-01-05 2025-07-10 L'oreal Composition for caring for and/or making up keratin materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012644A1 (de) * 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12
DE102010030443A1 (de) * 2010-06-23 2011-01-05 Lr Health & Beauty Systems Gmbh Kosmetische Zusammensetzung und deren Verwendung
KR20180075424A (ko) * 2016-12-26 2018-07-04 씨제이제일제당 (주) 식물성 유지 및 알룰로스를 포함하는 크리머
AU2018435851B2 (en) * 2018-08-10 2022-10-27 Samyang Corporation Nutritional drink
CN110151588A (zh) * 2019-05-24 2019-08-23 广州维真渼生物科技有限公司 矿泉活肤水及其制备方法
ES3026513T3 (en) * 2019-07-12 2025-06-11 Chemvet Australia Pty Ltd Injectable nutritional supplement
CN116367816B (zh) * 2020-09-10 2025-12-16 帝斯曼知识产权资产管理有限公司 锁水磁石的用途

Similar Documents

Publication Publication Date Title
JP2019108388A5 (https=)
JP2019189650A5 (https=)
NO20045072L (no) Tablett med hoyt medikamentinnhold
JP2017214429A5 (https=)
JP2007501265A5 (https=)
RU2014129783A (ru) Композиции для ухода за полостью рта
JP2024014991A5 (https=)
JP2025123521A5 (https=)
JP2019533679A5 (https=)
JP2018154613A5 (https=)
AR054609A1 (es) Composiciones similares a batido que contienen agente de solidificacion y metodos para prepararlas y usarlas
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
WO2022240379A3 (en) A stable pharmaceutical composition comprising selexipag
NO20062082L (no) Pellets inneholdende venlafaksinhydroklorid
JP2023112106A5 (https=)
JPWO2023198854A5 (https=)
JP2004519494A5 (https=)
JP2020510619A5 (https=)
RU2006137282A (ru) Химически устойчивые композиции 4-гидрокси-тамоксифена
JPWO2022244696A5 (https=)
JP2011529936A5 (https=)
HRP20161594T1 (hr) Pripravci za liječenje rozaceje koji sadrže kitozan i amid dikarboksilne kiseline
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
Hidaka et al. Relaxation of isolated rabbit arteries by fusaric (5-butylpicolinic) acid.
JPWO2023198855A5 (https=)